SG11201900005YA - Ghrelin secretion promotor - Google Patents
Ghrelin secretion promotorInfo
- Publication number
- SG11201900005YA SG11201900005YA SG11201900005YA SG11201900005YA SG11201900005YA SG 11201900005Y A SG11201900005Y A SG 11201900005YA SG 11201900005Y A SG11201900005Y A SG 11201900005YA SG 11201900005Y A SG11201900005Y A SG 11201900005YA SG 11201900005Y A SG11201900005Y A SG 11201900005YA
- Authority
- SG
- Singapore
- Prior art keywords
- ghrelin
- ghrelin secretion
- familiar
- easy
- safe
- Prior art date
Links
- 102000012004 Ghrelin Human genes 0.000 title abstract 4
- 101800001586 Ghrelin Proteins 0.000 title abstract 4
- GNKDKYIHGQKHHM-RJKLHVOGSA-N ghrelin Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)COC(=O)CCCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 GNKDKYIHGQKHHM-RJKLHVOGSA-N 0.000 title abstract 4
- 230000028327 secretion Effects 0.000 title abstract 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 206010063743 Hypophagia Diseases 0.000 abstract 1
- 230000004596 appetite loss Effects 0.000 abstract 1
- 235000015140 cultured milk Nutrition 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
- 235000021266 loss of appetite Nutrition 0.000 abstract 1
- 208000019017 loss of appetite Diseases 0.000 abstract 1
- 230000003248 secreting effect Effects 0.000 abstract 1
- 235000020270 seed milk Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/145—Gasseri
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Physiology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016139372A JP6813974B2 (ja) | 2016-07-14 | 2016-07-14 | グレリン分泌促進剤 |
| PCT/JP2017/025506 WO2018012578A1 (ja) | 2016-07-14 | 2017-07-13 | グレリン分泌促進剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201900005YA true SG11201900005YA (en) | 2019-02-27 |
Family
ID=60953153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201900005YA SG11201900005YA (en) | 2016-07-14 | 2017-07-13 | Ghrelin secretion promotor |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210290699A1 (zh) |
| JP (1) | JP6813974B2 (zh) |
| CN (2) | CN109715180B (zh) |
| SG (1) | SG11201900005YA (zh) |
| WO (1) | WO2018012578A1 (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108094541A (zh) * | 2018-01-11 | 2018-06-01 | 黑龙江完达山林海液奶有限公司 | 一种具有保健益生功能的风味发酵乳及其制备方法 |
| JP6515244B2 (ja) * | 2018-11-14 | 2019-05-15 | 株式会社明治 | グレリン分泌促進剤 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1981516B1 (en) * | 2006-01-27 | 2018-08-08 | DuPont Nutrition Biosciences ApS | Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders |
| CA2694384A1 (en) * | 2007-07-25 | 2009-01-29 | Campina Nederland Holding B.V. | Probiotics for inducing satiety and/or satiation |
| DK2123168T3 (da) * | 2008-05-16 | 2012-04-10 | Nestec Sa | Lactobacillus paracasei og vægtkontrol |
| JP5116731B2 (ja) * | 2009-06-29 | 2013-01-09 | 株式会社明治 | 発酵乳の製造方法 |
| SG10201600578UA (en) * | 2011-01-25 | 2016-02-26 | Meiji Co Ltd | Gastrin Production Inhibitor and Food Composition Comprising Same |
| JP5967527B2 (ja) * | 2012-06-22 | 2016-08-10 | 国立研究開発法人産業技術総合研究所 | 食欲増進かつ体重増加抑制剤 |
| JP6781887B2 (ja) * | 2014-02-28 | 2020-11-11 | 株式会社明治 | 機能性消化管障害予防及び／又は改善剤 |
| JP2015205829A (ja) * | 2014-04-18 | 2015-11-19 | 雪印メグミルク株式会社 | ホルモン分泌促進剤 |
| WO2015172191A1 (en) * | 2014-05-12 | 2015-11-19 | Medlab Ip Pty Ltd | Probiotic compositions and uses thereof for treatment of obesity-related disorders |
| SG11201610051YA (en) * | 2014-06-25 | 2017-01-27 | Meiji Co Ltd | Ghrelin secretion promoter |
| JP5950993B2 (ja) * | 2014-12-25 | 2016-07-13 | アサヒグループホールディングス株式会社 | 迷走神経活性化剤 |
-
2016
- 2016-07-14 JP JP2016139372A patent/JP6813974B2/ja active Active
-
2017
- 2017-07-13 US US16/316,078 patent/US20210290699A1/en not_active Abandoned
- 2017-07-13 WO PCT/JP2017/025506 patent/WO2018012578A1/ja active Application Filing
- 2017-07-13 CN CN201780043060.3A patent/CN109715180B/zh active Active
- 2017-07-13 CN CN202211713707.8A patent/CN115918726A/zh active Pending
- 2017-07-13 SG SG11201900005YA patent/SG11201900005YA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20210290699A1 (en) | 2021-09-23 |
| JP2018008901A (ja) | 2018-01-18 |
| CN115918726A (zh) | 2023-04-07 |
| JP6813974B2 (ja) | 2021-01-13 |
| CN109715180B (zh) | 2022-11-29 |
| WO2018012578A1 (ja) | 2018-01-18 |
| CN109715180A (zh) | 2019-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022005890A (es) | Metodos para mejorar la produccion de leche mediante la administracion de consorcios microbianos. | |
| MX2017004904A (es) | Cuerpo de planta injertada y método para producirlo. | |
| EP3473726B8 (en) | Fermentation technique to improve production level of recombinant human collagen | |
| PH12015500633A1 (en) | Method for preparing imp fermented broth or glutamic acid fermented broth as raw material for preparation of natural flavor | |
| MX2017008813A (es) | Polvo de coleopteros. | |
| MX2020003387A (es) | Producto alimenticio no lacteo fermentado. | |
| MY182593A (en) | Composition containing chitin and digestible proteins | |
| MX2017016283A (es) | Lactobacillus paracasei para la produccion de acido linoleico conjugado, preparaciones nutricionales y farmaceuticas que lo contienen y sus usos. | |
| PH12020550169A1 (en) | Isothiocyanate containing brassicaceae products and method of preparation thereof | |
| MX2016016871A (es) | Metodo para mejorar el valor nutricional de pienso para animales. | |
| PH12016501087B1 (en) | Lactobacillus salivarius for the treatment of mastitis | |
| MY184520A (en) | Method for preparing natural kokumi flavor | |
| MX2018002307A (es) | Bacteria lactobacillus fermentum que reduce la concentracion de acetaldehido. | |
| NZ733322A (en) | Grape products for nonalcoholic fatty liver disease and other uses | |
| EP3255140A4 (en) | Lactic acid bacteria, natural immunoactivator and infection preventative/therapeutic derived from said lactic acid bacteria, and food/beverage | |
| MX2016000661A (es) | Proceso para preparar un producto lácteo fermentado con una cantidad reducida de lactosa y propiedades nutricionales y organolépticas mejoradas. | |
| PH12020550463A1 (en) | Human milk fortifier composition | |
| TW201613631A (en) | Ghrelin secretion promoter | |
| SG11201900005YA (en) | Ghrelin secretion promotor | |
| MX2013012045A (es) | Péptidos con actividad antimicrobiana, composiciones farmacéuticas para la profilaxis y el tratamiento de animales, composiciones para la profilaxis y el tratamiento de vegetales, usos de esos péptidos y usos del extracto de paenibacillus elgii ourofinensis. | |
| MX2017001433A (es) | Sistema de bioprocesamiento a microescala y metodo para fabricacion de proteina a partir de sangre humana. | |
| PH12015500683A1 (en) | Formula fortifier | |
| PH12019500710A1 (en) | Methods and systems for generating a sterilized human milk product | |
| PH12017550065A1 (en) | Method for making a fermented food composition | |
| MX2018000613A (es) | Procedimiento para la preparacion de un producto fermentado de la leche. |